Moran W J, Toljanic J A, Panje W R
Section of Otolaryngology, University of Chicago Medical Center, Ill., USA.
Arch Otolaryngol Head Neck Surg. 1996 Jan;122(1):46-50. doi: 10.1001/archotol.1996.01890130040006.
To evaluate the use of endosseous transcutaneous implants to retain removable facial prostheses for the rehabilitation of orbital defects.
Tertiary referral center.
Six patients with a history of facial defects secondary to orbital exenteration for cancer ablation.
Clinically noted functional and cosmetic results, patient reports of satisfaction, and complications encountered.
Twenty-three of 25 implants were integrated (postoperative period, 13 to 65 months; mean, 44.2 months), representing an integration success rate of 92%. All patients were successfully wearing implant-retained prostheses after 48.3 months (post-prosthesis delivery period, 1 to 48.3 months; mean, 24.5 months). Overall patient satisfaction was very high.
Implant-retained prosthetics represent a safe and effective treatment option. It is anticipated that this treatment will become the standard of rehabilitative care for patients with orbital defects.
评估使用骨内穿皮种植体来固定可摘面部假体,用于眼眶缺损修复。
三级转诊中心。
6例因癌症消融行眼眶内容剜除术继发面部缺损的患者。
临床记录的功能和美容效果、患者满意度报告以及出现的并发症。
25枚种植体中有23枚成功整合(术后时间为13至65个月,平均44.2个月),整合成功率为92%。所有患者在48.3个月后均成功佩戴种植体固位假体(假体佩戴时间为1至48.3个月,平均24.5个月)。患者总体满意度很高。
种植体固位假体是一种安全有效的治疗选择。预计这种治疗将成为眼眶缺损患者康复护理的标准方法。